Chemomab Therapeutics Ltd. (CMMB) stock
Close on Nov 16, 2026Market cap $11.65MP/E 1.1Yield –
Earnings
Chemomab Therapeutics's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Chemomab Therapeutics's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | Aug 19, 2026before the open | – | – | $0.00 | Release |
| Q1 FY2026ended Mar 31, 2026 | May 14, 2026before the open | – | – | $0.00 | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 14, 2025before the open | – | – | – | Release |
| Q1 FY2025ended Mar 31, 2025 | May 15, 2025before the open | – | – | $0.01 | Release |
| Q4 FY2024ended Dec 31, 2024 | Mar 3, 2025before the open | – | – | $0.01 | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 21, 2024before the open | – | – | $0.01 | Release |
| Q1 FY2024ended Mar 31, 2024 | May 9, 2024before the open | – | – | $0.01 | Release |
| Q4 FY2023ended Dec 31, 2023 | Mar 7, 2024before the open | – | – | $0.01 | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 14, 2023before the open | – | – | $0.04 | Release |
| Q1 FY2023ended Mar 31, 2023 | May 11, 2023before the open | – | – | -$0.04 | Release |
| Q4 FY2022ended Dec 31, 2022 | Feb 21, 2023before the open | – | – | – | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 12, 2022before the open | – | – | – | Release |
| Q1 FY2022ended Mar 31, 2022 | May 12, 2022before the open | – | – | – | Release |
| Q4 FY2021ended Dec 31, 2021 | Mar 9, 2022before the open | – | – | – | Release |
| Q3 FY2021ended Sep 30, 2021 | Nov 12, 2021before the open | – | – | – | Release |
| Q2 FY2021ended Jun 30, 2021 | Aug 13, 2021before the open | – | – | – | Filing |
| Q1 FY2021ended Mar 31, 2021 | May 13, 2021before the open | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Guidance
Chemomab Therapeutics has not given guidance in its releases
Many companies give their outlook only on the conference call or not at all. When Chemomab Therapeutics puts a forecast in an earnings release, it is listed here with the exact sentence.
Press releases
Releases Chemomab Therapeutics filed with the SEC as exhibits to Form 8-K or 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
See a number that looks wrong?